The trajectory of companies tied to iconic drugs like Viagra presents a complex investment landscape . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial profits , the expiry in key territories has introduced considerable uncertainty . Investors are now facing the consequences of rival medication